Refractory anemia in a patient with allergy to intravenous iron drugs.
Fishbane
S
S
Winthrop University Hospital, Mineola, New York 11501, USA. sfishbane@metroenal.com
D000284:Administration, Oral; D000753:Anemia, Refractory / Q000209:etiology* / Q000628:therapy*; D001794:Blood Pressure / Q000187:drug effects; D001803:Blood Transfusion; D004921:Erythropoietin / Q000627:therapeutic use; D005260:Female; D005500:Follow-Up Studies; D006454:Hemoglobins / Q000032:analysis; D006801:Humans; D007275:Injections, Intravenous; D007501:Iron / Q000008:administration & dosage*; D000090463:Iron Deficiencies; D007505:Iron-Dextran Complex / Q000008:administration & dosage / Q000009:adverse effects; D007676:Kidney Failure, Chronic / Q000097:blood / Q000150:complications / Q000628:therapy; D008875:Middle Aged; D011994:Recombinant Proteins; D013997:Time Factors; D016896:Treatment Outcome
D006454:Hemoglobins; D011994:Recombinant Proteins; D004921:Erythropoietin; D007505:Iron-Dextran Complex; D007501:Iron